首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-beta-cyclodextrin.
【24h】

Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-beta-cyclodextrin.

机译:盐酸二甲双胍与三乙酰基-β-环糊精的二元体系的物理化学特征。

获取原文
获取原文并翻译 | 示例
           

摘要

Interaction products of metformin hydrochloride (MF.HCl), an oral anti-hyperglycaemic agent highly soluble in water, with triacetyl-beta-cyclodextrin (TAbetaCyD), a hydrophobic CyD derivative practically insoluble in water, were prepared to evaluate their suitability for the development of a sustained-release dosage form of the drug. Equimolar MF.HCl-TAbetaCyD solid compounds were obtained by different techniques, i.e., physical mixing, kneading, co-grinding, sealed-heating, and spray-drying, in order to investigate and compare their effectiveness and influence on the physical-chemical properties of the final products. Differential scanning calorimetry, X-ray powder diffractometry, Fourier transform infrared spectroscopy and scanning electron microscopy were used for the solid-state characterization of the different MF.HCl-TAbetaCyD systems, whereas their in vitro dissolution properties were determined according to the dispersed amount method. According to the results of solid-state studies, the ability of the different preparation methods to promote effective interactions between drug and CyD varied in the order: spray-drying>co-grinding>kneading>sealed-heating approximately physical mixing. The same effectiveness rank order was observed also in dissolution studies. In fact the time to dissolve 100% drug varied increased from 1 min, for pure drug, to 3, 7, 40, 120 up to 420 min for physically mixed, sealed-heated, kneaded, co-ground and spray-dried products, respectively. Thus the drug-TA(CyD products obtained by spray drying and co-grinding were selected as the best candidates for the future development of a suitable prolonged-release oral dosage form of MF.HCl.
机译:制备了盐酸二甲双胍(MF.HCl)(一种高度可溶于水的口服降血糖药)与实际上不溶于水的疏水性CyD衍生物三乙酰-β-环糊精(TAbetaCyD)的相互作用产物,以评估其在开发中的适用性药物的缓释剂型。通过物理混合,捏合,共研磨,密封加热和喷雾干燥等不同技术获得等摩尔的MF.HCl-TAbetaCyD固体化合物,以研究和比较它们的有效性及其对理化性质的影响最终产品。使用差示扫描量热法,X射线粉末衍射法,傅立叶变换红外光谱法和扫描电子显微镜对不同的MF.HCl-TAbetaCyD体系进行固相表征,而根据分散量法确定它们的体外溶出性质。根据固态研究的结果,不同制备方法促进药物与CyD之间有效相互作用的能力按以下顺序变化:喷雾干燥>共研磨>捏合>密封加热近似物理混合。在溶出度研究中也观察到相同的有效性等级顺序。实际上,溶解100%药物的时间从纯药物的1分钟增加到物理混合,密封加热,捏合,共同研磨和喷雾干燥产品的3、7、40、120到420分钟,分别。因此,通过喷雾干燥和共研磨获得的药物TA(CyD)产品被选为未来开发合适的MF.HCl口服剂型的最佳选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号